NCT06754371View on ClinicalTrials.gov

Prophylactic Tranexamic Acid Reduces Postpartum Hemorrhage

PHASE4RecruitingINTERVENTIONAL
Enrollment

276

Participants

Timeline

Start Date

January 6, 2025

Primary Completion Date

January 31, 2027

Study Completion Date

June 30, 2027

Conditions
Postpartum HemorrhageSystemic Autoimmune Diseases
Interventions
DRUG

tranexamic acid

intravenous infusion of tranexamic acid 1g (20ml) 10min before skin dissection

DRUG

normal saline

intravenous infusion of normal saline 20ml 10min before skin dissection

Trial Locations (1)

Unknown

RECRUITING

Renji Hospital, Shanghai Jiaotong University, School of Medcine, Shanghai

All Listed Sponsors
lead

RenJi Hospital

OTHER

NCT06754371 - Prophylactic Tranexamic Acid Reduces Postpartum Hemorrhage | Biotech Hunter | Biotech Hunter